Search research articles
Contact Us
Filters
Showing results (161-170 of 199) with videos related to
Page
of 20
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Karina Leal, Elizabeth L Zoeller, Gregory A Cary, et al.
The Journal of Biological Chemistry
|
January 5, 2012
Acridine yellow G blocks glioblastoma growth via dual inhibition of epidermal growth factor receptor and protein kinase C kinases
Qi Qi, Kunyan He, Min-Heui Yoo, et al.
British Journal of Cancer
|
July 20, 2023
Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models
Xin Li, Yanhua Chen, Lijuan Bai, et al.
Cancer Research
|
August 29, 2024
Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Junghui Koo, Chang-Soo Seong, Rebecca E Parker, et al.
Molecular Cell
|
June 2, 2009
Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis
Joseph E Aslan, Huihong You, Danielle M Williamson, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML
James M Kelvin, Juhi Jain, Aashis Thapa, et al.
Theranostics
|
June 7, 2021
Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer
Xin Li, Lajos Gera, Shumin Zhang, et al.
Molecular Cell
|
December 27, 2011
Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism
Taro Hitosugi, Jun Fan, Tae-Wook Chung, et al.
Nature Structural & Molecular Biology
|
August 24, 2010
14-3-3 adaptor proteins recruit AID to 5'-AGCT-3'-rich switch regions for class switch recombination
Zhenming Xu, Zsolt Fulop, Guikai Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 15, 2013
Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer
Suresh S Ramalingam, Taofeek K Owonikoko, Madhusmita Behera, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 199) with videos related to
Sort By:
Page
of 20
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Karina Leal, Elizabeth L Zoeller, Gregory A Cary, et al.
The Journal of Biological Chemistry
|
January 5, 2012
Acridine yellow G blocks glioblastoma growth via dual inhibition of epidermal growth factor receptor and protein kinase C kinases
Qi Qi, Kunyan He, Min-Heui Yoo, et al.
British Journal of Cancer
|
July 20, 2023
Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models
Xin Li, Yanhua Chen, Lijuan Bai, et al.
Cancer Research
|
August 29, 2024
Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Junghui Koo, Chang-Soo Seong, Rebecca E Parker, et al.
Molecular Cell
|
June 2, 2009
Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis
Joseph E Aslan, Huihong You, Danielle M Williamson, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML
James M Kelvin, Juhi Jain, Aashis Thapa, et al.
Theranostics
|
June 7, 2021
Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer
Xin Li, Lajos Gera, Shumin Zhang, et al.
Molecular Cell
|
December 27, 2011
Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism
Taro Hitosugi, Jun Fan, Tae-Wook Chung, et al.
Nature Structural & Molecular Biology
|
August 24, 2010
14-3-3 adaptor proteins recruit AID to 5'-AGCT-3'-rich switch regions for class switch recombination
Zhenming Xu, Zsolt Fulop, Guikai Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 15, 2013
Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer
Suresh S Ramalingam, Taofeek K Owonikoko, Madhusmita Behera, et al.
Page
of 20